Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$98.98 - $115.74 $1.81 Million - $2.12 Million
-18,328 Reduced 66.03%
9,430 $1.09 Million
Q2 2023

Jul 31, 2023

BUY
$96.34 - $112.38 $927,272 - $1.08 Million
9,625 Added 53.08%
27,758 $2.85 Million
Q1 2023

May 10, 2023

SELL
$107.32 - $113.5 $274,202 - $289,992
-2,555 Reduced 12.35%
18,133 $1.98 Million
Q4 2022

Feb 07, 2023

SELL
$62.39 - $113.8 $987,820 - $1.8 Million
-15,833 Reduced 43.35%
20,688 $2.35 Million
Q3 2022

Nov 14, 2022

BUY
$58.92 - $84.67 $454,391 - $652,975
7,712 Added 26.77%
36,521 $2.26 Million
Q2 2022

Aug 12, 2022

BUY
$79.4 - $116.36 $927,074 - $1.36 Million
11,676 Added 68.15%
28,809 $2.3 Million
Q1 2022

May 16, 2022

SELL
$86.42 - $109.81 $1.05 Million - $1.33 Million
-12,106 Reduced 41.4%
17,133 $1.8 Million
Q4 2021

Feb 14, 2022

BUY
$98.56 - $119.91 $171,297 - $208,403
1,738 Added 6.32%
29,239 $3.15 Million
Q3 2021

Nov 15, 2021

SELL
$91.91 - $110.37 $53,675 - $64,456
-584 Reduced 2.08%
27,501 $3.01 Million
Q2 2021

Aug 13, 2021

BUY
$86.24 - $95.92 $363,932 - $404,782
4,220 Added 17.68%
28,085 $2.63 Million
Q1 2021

May 14, 2021

BUY
$71.83 - $95.48 $243,647 - $323,868
3,392 Added 16.57%
23,865 $2.2 Million
Q4 2020

Feb 12, 2021

BUY
$67.0 - $84.39 $448,297 - $564,653
6,691 Added 48.55%
20,473 $1.5 Million
Q3 2020

Nov 09, 2020

BUY
$55.23 - $79.93 $186,677 - $270,163
3,380 Added 32.49%
13,782 $1.07 Million
Q2 2020

Aug 13, 2020

BUY
$30.2 - $56.98 $314,140 - $592,705
10,402 New
10,402 $578,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.